CBDG (THC Farmaceuticals) Change In Receivables: $-0.00 Mil (TTM As of Jun. 2018)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is THC Farmaceuticals Change In Receivables?

THC Farmaceuticals CBDG Change In Receivables is $-0.00 Mil as of Jun. 2018.

THC Farmaceuticals's change in receivables for the quarter that ended in Jun. 2018 was $0.00 Mil. It means THC Farmaceuticals's Accounts Receivable stayed the same from Mar. 2018 to Jun. 2018 .

THC Farmaceuticals's change in receivables for the fiscal year that ended in Sep. 2013 was $0.00 Mil. It means THC Farmaceuticals's Accounts Receivable stayed the same from Sep. 2012 to Sep. 2013 .

THC Farmaceuticals's Accounts Receivable for the quarter that ended in Jun. 2018 was $0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. THC Farmaceuticals's Days Sales Outstanding for the three months ended in Jun. 2018 was 45.63.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. THC Farmaceuticals's liquidation value for the three months ended in Jun. 2018 was $-0.97 Mil.

THC Farmaceuticals  (OTCPK:CBDG) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

THC Farmaceuticals's Days Sales Outstanding for the quarter that ended in Jun. 2018 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=0.001/0.002*91
=45.63

2. In Ben Graham's calculation of liquidation value, THC Farmaceuticals's accounts receivable are only considered to be worth 75% of book value:

THC Farmaceuticals's liquidation value for the quarter that ended in Jun. 2018 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=0.002-0.968+0.75 * 0.001+0.5 * 0
=-0.97

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

THC Farmaceuticals Change In Receivables Related Terms

THC Farmaceuticals Change In Receivables Historical Data

* Premium members only.

The historical data trend for THC Farmaceuticals's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

THC Farmaceuticals Change In Receivables Chart

THC Farmaceuticals Annual Data
Trend Sep10 Sep11 Sep12 Sep13
Change In Receivables
0.00 0.00 0.00 0.00

THC Farmaceuticals Quarterly Data
Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Mar17 Jun17 Mar18 Jun18
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.58 0.00 0.00 -0.00 0.00

THC Farmaceuticals Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Receivables →
What does a Change In Receivables of $-0.00 Mil mean?
THC Farmaceuticals (CBDG) has a Change In Receivables of $-0.00 Mil as of Jun. 2018. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for THC Farmaceuticals and its competitors.
Is THC Farmaceuticals' Change In Receivables too high?
THC Farmaceuticals' current Change In Receivables is $-0.00 Mil.
How does THC Farmaceuticals' Change In Receivables compare to BOXS?
THC Farmaceuticals' Change In Receivables of $-0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Biotechnology company?
A good Change In Receivables depends on the Biotechnology industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for THC Farmaceuticals and its competitors. THC Farmaceuticals's current Change In Receivables is $-0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is THC Farmaceuticals stock overvalued right now?
THC Farmaceuticals (CBDG) has a current Change In Receivables of $-0.00 Mil. The current Change In Receivables is $-0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For THC Farmaceuticals (CBDG), the current Change In Receivables is $-0.00 Mil as of Jun. 2018. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

THC Farmaceuticals Business Description

Address 2789 Rio Vista Drive, Suite 3, Saint George, UT, USA, 84790
THC Farmaceuticals Inc is a clinical-stage biotechnology company specializing in the discovery, development, and commercialization of novel cannabinoid-based products in dental, ophthalmology, and other medical disciplines. It offers the combination of proprietary developments with the expertise of clinicians and scientists to unlock the therapeutic properties of cannabis and its bioactive compounds.